Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Blood (2024) 143 (17): 1738–1751.

https://doi.org/10.1182/blood.2023021952

Published: 2024

Includes: Supplemental data

Journal Articles

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Gudrun Fleischhack, Norbert Graf, Thomas Klingebiel, Bernhard Kremens, Thomas Lehrnbecher, Christine von Neuhoff, Jörg Ritter, Annette Sander, André Schrauder, Arend von Stackelberg, Jan Starý, Dirk Reinhardt

Blood (2013) 122 (1): 37–43.

https://doi.org/10.1182/blood-2013-02-484097

Published: 2013

Includes: Supplemental data

Journal Articles

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Blood (2012) 120 (16): 3187–3205.

https://doi.org/10.1182/blood-2012-03-362608

Published: 2012

Includes: Supplemental data

Journal Articles

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Ursula Creutzig, Martin Zimmermann, Jean-Pierre Bourquin, Michael N. Dworzak, Christine von Neuhoff, Annette Sander, André Schrauder, Andrea Teigler-Schlegel, Jan Starý, Selim Corbacioglu, Dirk Reinhardt

Blood (2011) 118 (20): 5409–5415.

https://doi.org/10.1182/blood-2011-07-364661

Published: 2011

Includes: Supplemental data

Journal Articles

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/ MLL -rearranged AML patients: results of an international study

Blood (2011) 117 (26): 7102–7111.

https://doi.org/10.1182/blood-2010-12-328302

Published: 2011

Includes: Supplemental data

Journal Articles

CD11b is a therapy resistance– and minimal residual disease–specific marker in precursor B-cell acute lymphoblastic leukemia

Peter Rhein, Rita Mitlohner, Giuseppe Basso, Giuseppe Gaipa, Michael N. Dworzak, Renate Kirschner-Schwabe, Christian Hagemeier, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Leonid Karawajew, Richard Ratei

Blood (2010) 115 (18): 3763–3771.

https://doi.org/10.1182/blood-2009-10-247585

Published: 2010

Journal Articles

Preventive CNS Irradiation with 12 Gy Compared to 18 Gy: Results of Studies AML-BFM 98 and 2004.

Ursula Creutzig, MD, Martin Zimmermann, PhD, Joerg Ritter, MD, Norbert Graf, MD, Thomas Lehrnbecher, Jean-Pierre Bourquin, MD, PhD, Arend Stackelberg, Michael N Dworzak, MD, PhD, Jan Starý, MD, Dirk Reinhardt, MD, PhD

Blood (2009) 114 (22): 483.

https://doi.org/10.1182/blood.V114.22.483.483

Published: 2009

Journal Articles

Novel prognostic subgroups in childhood 11q23/ MLL -rearranged acute myeloid leukemia: results of an international retrospective study

Blood (2009) 114 (12): 2489–2496.

https://doi.org/10.1182/blood-2009-04-215152

Published: 2009

Includes: Supplemental data

Journal Articles

Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group

Giuseppe Gaipa, MD, Giovanni Cazzaniga, Renate E Panzer-Grümayer, Marinella Veltroni, Leonid Karawajew, Daniela Silvestri, Barbara Buldini, Richard Ratei, Andre Schrauder, Martin Schrappe, Wolf-Dieter Ludwig, Maria Grazia Valsecchi, Andrea Biondi, Michael N Dworzak, Giuseppe Basso

Blood (2008) 112 (11): 700.

https://doi.org/10.1182/blood.V112.11.700.700

Published: 2008

Journal Articles

MRD Monitoring of Childhood ALL Using Hierarchical Clustering and Support Vector Machine Learning of Complex Multi-Parameter Flow Cytometry Data.

Karel Fiser, PhD, Tomas Sieger, MSc, Angela Schumich, Julie Irving, PhD, Michael N Dworzak, MD, Josef Vormoor, MD, FRCPCH

Blood (2008) 112 (11): 1508.

https://doi.org/10.1182/blood.V112.11.1508.1508

Published: 2008

Journal Articles

Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98.

Christine von Neuhoff, MD, Jutta Bradtke, Martin Zimmermann, PhD, Jean-Pierre Bourquin, MD, PhD, David Betts, BSc, Jan Stary, MD, PhD, Zuzana Zemanova, MD, Michael N Dworzak, MD, PhD, Dirk Reinhardt, MD, PhD, U. Creutzig

Blood (2008) 112 (11): 1510.

https://doi.org/10.1182/blood.V112.11.1510.1510

Published: 2008

Journal Articles

Integrin Alpha M Chain Expression at Diagnosis Is Inversely Correlated with Cytoreduction Rate and Is Consistently Up-Regulated during Therapy in Acute Lymphoblastic Leukemia (ALL)

Peter Rhein, Richard Ratei, MD, Rita Mitlohner, Giuseppe Basso, MD, Giuseppe Gaipa, MD, Michael N Dworzak, MD, PhD, Martin Stanulla, MD, Martin Schrappe, MD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD

Blood (2008) 112 (11): 2526.

https://doi.org/10.1182/blood.V112.11.2526.2526

Published: 2008

Journal Articles

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

Michael N. Dworzak, Angela Schumich, Dieter Printz, Ulrike Pötschger, Zvenyslava Husak, Andishe Attarbaschi, Giuseppe Basso, Giuseppe Gaipa, Richard Ratei, Georg Mann, Helmut Gadner

Blood (2008) 112 (10): 3982–3988.

https://doi.org/10.1182/blood-2008-06-164129

Published: 2008

Journal Articles

Treatment Response and Outcome in Childhood t(1;19)/ TCF3-PBX1 Positive Acute Lymphoblastic Leukemia: A Report from the Austrian BFM Group.

Leo Kager, MD, Thomas Lion, MD, PhD, Andishe Attarbaschi, MD, Margit Koenig, PhD, Sabine Strehl, PhD, Oskar A. Haas, MD, Michael N. Dworzak, MD, Martin Schrappe, MD, PhD, Helmut Gadner, MD, Georg Mann, MD

Blood (2005) 106 (11): 1458.

https://doi.org/10.1182/blood.V106.11.1458.1458

Published: 2005

Journal Articles

Feasibility of Multicentric Assessment of MRD in All by Flow-Cytometry: Standardization and Experience of the I-BFM-ALL FCM-MRD Study Group.

Giuseppe Gaipa, PhD, Marinella Veltroni, PhD, Richard Ratei, MD, Wolf-Dieter Ludwig, MD, Andrea Biondi, MD, Giuseppe Basso, MD, Michael N. Dworzak, MD

Blood (2004) 104 (11): 1079.

https://doi.org/10.1182/blood.V104.11.1079.1079

Published: 2004

Journal Articles

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia

Michael N. Dworzak, Gertraud Fröschl, Dieter Printz, Georg Mann, Ulrike Pötschger, Nora Mühlegger, Gerhard Fritsch, Helmut Gadner

Blood (2002) 99 (6): 1952–1958.

https://doi.org/10.1182/blood.V99.6.1952

Published: 2002

Journal Articles

Four-Color Flow Cytometric Investigation of Terminal Deoxynucleotidyl Transferase–Positive Lymphoid Precursors in Pediatric Bone Marrow: CD79a Expression Precedes CD19 in Early B-Cell Ontogeny

Michael N. Dworzak, Gerhard Fritsch, Gertraud Fröschl, Dieter Printz, Helmut Gadner

Blood (1998) 92 (9): 3203–3209.

https://doi.org/10.1182/blood.V92.9.3203

Published: 1998

NARROW

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004

Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel

Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16)

Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/ MLL -rearranged AML patients: results of an international study

CD11b is a therapy resistance– and minimal residual disease–specific marker in precursor B-cell acute lymphoblastic leukemia

Preventive CNS Irradiation with 12 Gy Compared to 18 Gy: Results of Studies AML-BFM 98 and 2004.

Novel prognostic subgroups in childhood 11q23/ MLL -rearranged acute myeloid leukemia: results of an international retrospective study

Time Point-Dependent Concordance of Flow Cytometry and RQ-PCR in the MRD Detection in Childhood ALL: The Experience of the AIEOP-BFM- ALL MRD Study Group

MRD Monitoring of Childhood ALL Using Hierarchical Clustering and Support Vector Machine Learning of Complex Multi-Parameter Flow Cytometry Data.

Distribution and Outcome According to Cytogenetics in 502 Paediatric AML Patients Treated in Study AML-BFM 98.

Integrin Alpha M Chain Expression at Diagnosis Is Inversely Correlated with Cytoreduction Rate and Is Consistently Up-Regulated during Therapy in Acute Lymphoblastic Leukemia (ALL)

CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy

Treatment Response and Outcome in Childhood t(1;19)/ TCF3-PBX1 Positive Acute Lymphoblastic Leukemia: A Report from the Austrian BFM Group.

Feasibility of Multicentric Assessment of MRD in All by Flow-Cytometry: Standardization and Experience of the I-BFM-ALL FCM-MRD Study Group.

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia

Four-Color Flow Cytometric Investigation of Terminal Deoxynucleotidyl Transferase–Positive Lymphoid Precursors in Pediatric Bone Marrow: CD79a Expression Precedes CD19 in Early B-Cell Ontogeny

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only